BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 2946956)

  • 1. Selective loss of the suppressor-inducer T-cell subset in progressive multiple sclerosis. Analysis with anti-2H4 monoclonal antibody.
    Morimoto C; Hafler DA; Weiner HL; Letvin NL; Hagan M; Daley J; Schlossman SF
    N Engl J Med; 1987 Jan; 316(2):67-72. PubMed ID: 2946956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The isolation and characterization of the human suppressor inducer T cell subset.
    Morimoto C; Letvin NL; Distaso JA; Aldrich WR; Schlossman SF
    J Immunol; 1985 Mar; 134(3):1508-15. PubMed ID: 3155770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the 2H4 molecule in the activation of suppressor inducer function.
    Morimoto C; Matsuyama T; Rudd CE; Forsgren A; Letvin NL; Schlossman SF
    Eur J Immunol; 1988 May; 18(5):731-7. PubMed ID: 2967762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of suppression following autologous mixed lymphocyte reaction; role of a novel 2H4 antigen.
    Takeuchi T; Rudd CE; Schlossman SF; Morimoto C
    Eur J Immunol; 1987 Jan; 17(1):97-103. PubMed ID: 2949986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decrease of suppressor inducer (CD4+2H4+) T cells in multiple sclerosis cerebrospinal fluid.
    Chofflon M; Weiner HL; Morimoto C; Hafler DA
    Ann Neurol; 1989 May; 25(5):494-9. PubMed ID: 2528316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of functional suppression is linked to decreases in circulating suppressor inducer (CD4+ 2H4+) T cells in multiple sclerosis.
    Chofflon M; Weiner HL; Morimoto C; Hafler DA
    Ann Neurol; 1988 Aug; 24(2):185-91. PubMed ID: 2972249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The isolation and characterization of the human helper inducer T cell subset.
    Morimoto C; Letvin NL; Boyd AW; Hagan M; Brown HM; Kornacki MM; Schlossman SF
    J Immunol; 1985 Jun; 134(6):3762-9. PubMed ID: 3157750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis.
    Hafler DA; Fox DA; Manning ME; Schlossman SF; Reinherz EL; Weiner HL
    N Engl J Med; 1985 May; 312(22):1405-11. PubMed ID: 2985995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of circulating suppressor inducer T lymphocytes in the exacerbation phase of remitting-relapse multiple sclerosis.
    Cafaro A; Spadaro M; Pandolfi F; Tilia G; Scarselli E; Liberati F; Aiuti F
    Riv Neurol; 1987; 57(3):159-62. PubMed ID: 2960006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoregulatory T-cells and lymphocytotoxic antibodies in active multiple sclerosis: weekly analysis over a six-month period.
    Hauser SL; Reinherz EL; Hoban CJ; Schlossman SF; Weiner HL
    Ann Neurol; 1983 Apr; 13(4):418-25. PubMed ID: 6220668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The T4 molecule differentially regulating the activation of subpopulations of T4+ cells.
    Takeuchi T; Schlossman SF; Morimoto C
    J Immunol; 1987 Aug; 139(3):665-71. PubMed ID: 2955047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cellular basis for the induction of antigen-specific T8 suppressor cells.
    Morimoto C; Letvin NL; Distaso JA; Brown HM; Schlossman SF
    Eur J Immunol; 1986 Feb; 16(2):198-204. PubMed ID: 2420607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of suppressor T cells in active multiple sclerosis. Analysis with monoclonal antibodies.
    Reinherz EL; Weiner HL; Hauser SL; Cohen JA; Distaso JA; Schlossman SF
    N Engl J Med; 1980 Jul; 303(3):125-9. PubMed ID: 6446039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of low dose cyclophosphamide on the immune system of cancer patients: depletion of CD4+, 2H4+ suppressor-inducer T-cells.
    Berd D; Mastrangelo MJ
    Cancer Res; 1988 Mar; 48(6):1671-5. PubMed ID: 2830969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A serial study of peripheral blood T lymphocyte subsets in relapsing-remitting multiple sclerosis.
    Kastrukoff LF; Paty DW
    Ann Neurol; 1984 Mar; 15(3):250-6. PubMed ID: 6232891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoregulatory subsets of the T helper and T suppressor cell populations in homosexual men with chronic unexplained lymphadenopathy.
    Nicholson JK; McDougal JS; Spira TJ; Cross GD; Jones BM; Reinherz EL
    J Clin Invest; 1984 Jan; 73(1):191-201. PubMed ID: 6228564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressor T-lymphocytes in multiple sclerosis: analysis of patients with acute relapsing and chronic progressive disease.
    Paty DW; Kastrukoff L; Morgan N; Hiob L
    Ann Neurol; 1983 Oct; 14(4):445-9. PubMed ID: 6227277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decrease in phenotypically defined T helper inducer cells (T4+4B4+) and increase in T suppressor effector cells (T8+2H4+) in stable renal allograft recipients.
    Ramos EL; Turka LA; Leggat JE; Wood IG; Milford EL; Carpenter CB
    Transplantation; 1989 Mar; 47(3):465-71. PubMed ID: 2522253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Peripheral blood lymphocyte subsets in acute relapsing multiple sclerosis].
    Yang YC
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1990 Jun; 23(3):146-9, 189. PubMed ID: 2143976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human epidermal cells from ultraviolet light-exposed skin preferentially activate autoreactive CD4+2H4+ suppressor-inducer lymphocytes and CD8+ suppressor/cytotoxic lymphocytes.
    Baadsgaard O; Fox DA; Cooper KD
    J Immunol; 1988 Mar; 140(6):1738-44. PubMed ID: 2964481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.